DiscoverThe Journal.The Quest to Save American-Made Antibiotics
The Quest to Save American-Made Antibiotics

The Quest to Save American-Made Antibiotics

Update: 2024-07-252
Share

Description

USAntibiotics's plant in Tennessee is one of the last plants in the United States that makes amoxicillin, the crucial antibiotic that has been in shortage in some forms since 2022. But the plant isn’t breaking even, financially. WSJ’s Liz Essley Whyte reports on why it is so hard for American-made generic drugs manufacturers to survive.




Further Listening:


- Will Florida’s Plan to Get Cheap Drugs From Canada Work? 


- Trillion Dollar Shot 




Further Reading:


- Drug Shortages in America Reach a Record High 


- Drug Shortages Trigger FTC Probe 




Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The Quest to Save American-Made Antibiotics

The Quest to Save American-Made Antibiotics

The Wall Street Journal & Gimlet